Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AbobotulinumtoxinA in Post-Traumatic Headache
NCT03928496Phase 4Completed
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- Aug 2013
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in post-traumatic headache (PTH), sponsored by VA Greater Los Angeles Healthcare System. Started Aug 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT03928496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928496.